4//SEC Filing
Gelder Mark S. MD 4
Accession 0001179110-21-007924
CIK 0001130598other
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 8:02 PM ET
Size
7.8 KB
Accession
0001179110-21-007924
Insider Transaction Report
Form 4
Gelder Mark S. MD
Chief Medical Officer
Transactions
- Award
Restricted Stock Units
2021-08-02+13,950→ 13,950 total→ Common stock (13,950 underlying) - Award
Stock Option (right to purchase)
2021-08-02+41,825→ 41,825 totalExercise: $5.19Exp: 2031-08-02→ Common stock (41,825 underlying)
Footnotes (3)
- [F1]These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years.
- [F2]These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary.
- [F3]Each restricted stock unit is convertible into one share of common stock.
Documents
Issuer
Onconova Therapeutics, Inc.
CIK 0001130598
Entity typeother
Related Parties
1- filerCIK 0001564390
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 8:02 PM ET
- Size
- 7.8 KB